
    132 A.3d 422
    IN RE REGLAN LITIGATION(PLIVA, INC.; BARR PHARMACEUTICALS, LLC; BARR LABORATORIES, INC.; WATSON LABORATORIES, INC.; ACTAVIS-ELIZABETH, LLC; TEVA PHARMACEUTICALS USA, INC.; MUTUAL PHARMACEUTICAL COMPANY, INC.; AND UNITED RESEARCH LABORATORIES, INC.—MOVANTS)
    April 24, 2015.
   It is ORDERED that the motion for leave to appeal is granted.  